Ray Dalio
HAE icon

Ray Dalio’s Haemonetics HAE Stock Holding History

Ray Dalio’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.48M Buy
59,733
+11,356
+23% +$729K 0.02% 499
2026
Q1 		$2.73M Buy
+48,377
New +$3.15M 0.01% 585
2025
Q4 		– Sell
-59,104
Closed -$2.88M – 1112
2025
Q3 		$2.88M Buy
59,104
+12,820
+28% +$794K 0.01% 633
2025
Q2 		$3.45M Buy
46,284
+24,764
+115% +$1.64M 0.01% 369
2025
Q1 		$1.37M Buy
21,520
+16,128
+299% +$1.1M 0.01% 490
2024
Q4 		$421K Sell
5,392
-2,434
-31% -$196K ﹤0.01% 595
2024
Q3 		$629K Sell
7,826
-35,747
-82% -$2.89M ﹤0.01% 666
2024
Q2 		$3.6M Sell
43,573
-3,206
-7% -$282K 0.02% 419
2024
Q1 		$3.99M Sell
46,779
-7,960
-15% -$625K 0.02% 407
2023
Q4 		$4.68M Sell
54,739
-5,413
-9% -$468K 0.03% 374
2023
Q3 		$5.39M Buy
60,152
+4,957
+9% +$443K 0.03% 351
2023
Q2 		$4.7M Sell
55,195
-6,434
-10% -$544K 0.03% 320
2023
Q1 		$5.1M Buy
61,629
+2,102
+4% +$170K 0.03% 306
2022
Q4 		$4.68M Sell
59,527
-21,454
-26% -$1.72M 0.03% 372
2022
Q3 		$6M Sell
80,981
-64
-0.1% -$4.6K 0.03% 343
2022
Q2 		$5.28M Buy
81,045
+7,552
+10% +$447K 0.02% 470
2022
Q1 		$4.65M Buy
73,493
+17,518
+31% +$953K 0.02% 491
2021
Q4 		$2.97M Buy
55,975
+8,306
+17% +$506K 0.02% 406
2021
Q3 		$3.36M Sell
47,669
-4,236
-8% -$267K 0.02% 352
2021
Q2 		$3.46M Buy
+51,905
New +$3.67M 0.02% 400

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Ariel Investments
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ray Dalio's HAE Position: Q2 2026 in Review

Ray Dalio increased its Haemonetics (HAE) stake by 23% in Q2 2026, buying an estimated $729K and bringing the position to 59,733 shares worth $4.48M. The position accounts for 0.02% of the portfolio, ranked #499.

Ray Dalio first reported a position in HAE in Q2 2021 and has held it in 20 quarters since. The position peaked at $6M in Q3 2022. 330 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Ray Dalio held 59,733 shares of Haemonetics worth $4.48M as of Q2 2026.
  • Ray Dalio bought 11,356 Haemonetics shares in Q2 2026, an estimated $729K.
  • Haemonetics made up 0.02% of Ray Dalio's portfolio in Q2 2026, its #499 holding.
  • Ray Dalio first reported a position in Haemonetics in Q2 2021 and has held it in 20 quarters since.
  • Ray Dalio's Haemonetics position peaked at $6M in Q3 2022.
  • 330 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Bridgewater Associates's 13F filing for Q2 2026, filed 14 Aug 2026.